Shots: reSET and reSET-O are the 1st US FDA authorized PDTs for patients (aged ≥ 18 yrs.) with substance use disorder and opioid use disorder. The availability of PDT’s with outpatient care will elevate the nation’s battle against the substance and opioid use crisis Wellpath Community Care Centers can use Pear’s reSET and reSET-O products […]Read More
Shots: The approval is based on trial results assessing reSET-O in 170 patients receiving either treatment-as-usual (TAU) + standard clinician interactions + buprenorphine or reSET-O + standard clinician interactions + buprenorphine for 12 wks. The study demonstrated improved and increase rates of retention time with efficacy results in patients with OUD reSET-O is a FDA […]Read More
Copyright ©2020 PharmaShots | Powered by Octavus Consulting
